Belando, Eddie E.
HRN: 24-98-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2024
CO-AMOXICLAV 625MG (TAB)
05/13/2024
05/20/2024
PO
625mg
BID
S/P Appendectomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes